Apogee Therapeutics, Inc. (NASDAQ:APGE) Poised To Extend Rally On Strong Momentum
Momentum indicators and moving-average structure favor continued upside in the near term, while fundamental losses and negative cash flow keep valuation elevated. Technical strength points toward further price discovery, balanced by fundamental constraints on long-term valuation.








